ANGELINI PHARMA SPA sell "HPAPI Platform"

In response to growing demand for custom HPAPIs, Angelini API Business is expanding its HPAPI capacity. Drawing on more than 50 years of CDMO experience, it leads chemical development and cGMP manufacturing of HPAPIs for the branded pharmaceutical industry. Its new HPAPI platform covers all manufacturing scales across the full OEL/OEB spectrum, supporting outsourcing needs from route selection and proof-of-concept runs through scale-up to small- and large-volume HPAPI cGMP manufacturing, with a smooth, safe and optimized technology transfer process.